Adams D E, Bliska J B, Cozzarelli N R
Department of Molecular and Cell Biology, University of California, Berkeley 94720.
J Mol Biol. 1992 Aug 5;226(3):661-73. doi: 10.1016/0022-2836(92)90623-r.
The mechanism of the Cre recombinase of bacteriophage P1 in Escherichia coli cells was analyzed by topological methods in order to determine the important features of the in vivo reaction. Lambda infection was used to introduce the cre gene into cells containing plasmid substrates. The products of Cre resolution on substrates with directly repeated sites were predominantly free circles, even though decatenation by DNA gyrase was blocked by the drug norfloxacin. Recombination by Cre was greatly stimulated by negative supercoiling, and inversion occurred inefficiently. These results are strikingly different from those found with purified enzyme in vitro. Our data imply that Cre recombination in vivo is much more tightly controlled than it is in vitro, and that Cre acts predominantly as a resolvase in vivo. We suggest a role for Cre-mediated recombination in P1 plasmid amplification that is consistent with the selectivity of the enzyme in vivo.
为了确定体内反应的重要特征,采用拓扑学方法分析了噬菌体P1的Cre重组酶在大肠杆菌细胞中的作用机制。利用λ噬菌体感染将cre基因导入含有质粒底物的细胞中。即使DNA促旋酶的解连环作用被诺氟沙星药物阻断,Cre在具有直接重复位点的底物上进行切割的产物主要仍是游离环。负超螺旋极大地刺激了Cre介导的重组,而倒位发生效率较低。这些结果与在体外使用纯化酶时得到的结果显著不同。我们的数据表明,Cre重组在体内比在体外受到更严格的控制,并且Cre在体内主要作为切割酶发挥作用。我们提出了Cre介导的重组在P1质粒扩增中的作用,这与该酶在体内的选择性一致。